Last reviewed · How we verify
[14C] AZD4635 IV microtracer - fasted — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
[14C] AZD4635 IV microtracer - fasted ([14C] AZD4635 IV microtracer - fasted) — AstraZeneca.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| [14C] AZD4635 IV microtracer - fasted TARGET | [14C] AZD4635 IV microtracer - fasted | AstraZeneca | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- [14C] AZD4635 IV microtracer - fasted CI watch — RSS
- [14C] AZD4635 IV microtracer - fasted CI watch — Atom
- [14C] AZD4635 IV microtracer - fasted CI watch — JSON
- [14C] AZD4635 IV microtracer - fasted alone — RSS
Cite this brief
Drug Landscape (2026). [14C] AZD4635 IV microtracer - fasted — Competitive Intelligence Brief. https://druglandscape.com/ci/14c-azd4635-iv-microtracer-fasted. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing